Eli Lilly stock slips despite steady GLP-1 script growth
Investing.com Gold reports: Eli Lilly stock slips despite steady GLP-1 script growth. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Eli Lilly stock slips despite steady GLP-1 script growth. Full body text was unavailable at ingest time, so this brief is based on headline context.